DYNAREX LAXATIVE- mineral oil liquid Bandaríkin - enska - NLM (National Library of Medicine)

dynarex laxative- mineral oil liquid

dynarex corporation - mineral oil (unii: t5l8t28fgp) (mineral oil - unii:t5l8t28fgp) - purpose relieves occassional constipation (irregularity). indications & usage - for relief of occassional constipation (irregularity). when using this product  - do not take with meals - take only at bedtime ask a doctor before use if you have - stomach reflux - abdominal pain, nausea, or vomiting - notice a sudden change in bowel habits that persist over a period of 2 weeks stop use and ask a doctor if - rectal bleeding or failure to have a bowel movementafter use. these could be signs of a serious condition.

DYNAREX GREEN- alcohol liquid Bandaríkin - enska - NLM (National Library of Medicine)

dynarex green- alcohol liquid

dynarex corporation - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - do not use with electrocautery procedures an antiseptic wash. cleaning and antiseptic cleansing of skin.

DYNAREX BURN CREAM- lidocaine cream Bandaríkin - enska - NLM (National Library of Medicine)

dynarex burn cream- lidocaine cream

dynarex corporation - active ingredient                                       purpose, lidocaine hcl 0.5%                                   topical analgesic, benzalkonium chloride 0.13%                    topical antiseptic - temporary relief of pain and itching. for temporary relief of pain and itching associated with: - sunburn - minor burns, - insect bites, - minor skin irritation, - cuts and  - scrapes stop use and ask a doctor: - if condition worsens or, - if symptoms persist for more than 7 days or clear up and occur again in a few days. - if pregnant or breast feeding, ask a health professional before use. do not use: - in the eyes - over large areas of the body or on deep puncture wounds, animal bites or serious burns. - in large quantities, particularly over raw surfaces or blistered areas.

DYNAREX ANTIFUNGAL- antifungal cream Bandaríkin - enska - NLM (National Library of Medicine)

dynarex antifungal- antifungal cream

dynarex corporation - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - - for treatment of most athlete's foot (tinea pedis), jock itch (tinea crusis), ringworm (tinea corporis). - for the treatment of superficial skin infections caused by yeast (candida albicans). - relieves itching, scaling, cracking, burning, redness, soreness, irritation discomfort and chafing associated with jock itch. - clean the affected area and dry thoroughly. apply a layer of cream over affected area twice daily (morning and night) or as directed by a doctor. - supervise children in the use of this product. - for athlete's foot, pay special attention to spaces between toes: wear well fitting, ventilated shoes, and change shoes and socks at least once daily.

DYNAREX ZINC OXIDE- zinc oxide ointment ointment Bandaríkin - enska - NLM (National Library of Medicine)

dynarex zinc oxide- zinc oxide ointment ointment

dynarex corporation - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - skin protectant - helps treat chafed skin associated with diaper rash - dries the oozing and weeping of poison: ■ ivy ■ oak ■ sumac

DYNAREX HYDROGEL- glycerin gel Bandaríkin - enska - NLM (National Library of Medicine)

dynarex hydrogel- glycerin gel

dynarex corporation - glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox) - for dressing and management of stasis ulcers, pressure ulcers (stages i-iv) 1st and 2nd degree burns, cuts abrasions, skin irritations, post operative incisions, and skin conditions associated with peristomal care. use: - for dressing and management of stasis ulcers, - pressure ulcers (stages i-iv) - 1st and 2nd degree burns, - cuts abrasions, - skin irritations, - post operative incisions, - and skin conditions associated with peristomal care.

DYNAREX ANTIFUNGAL POWDER- miconazole powder Bandaríkin - enska - NLM (National Library of Medicine)

dynarex antifungal powder- miconazole powder

dynarex corporation - miconazole nitrate (unii: vw4h1cyw1k) (miconazole - unii:7nno0d7s5m) - uses for external treatment of fungal infections such as athlete’s foot, jock itch, sweat rash, infected diaper rash and fungal infections affecting the skin folds e.g. armpits, groin, or under the breasts. do not use: ■ if you are sensitive to any of the active or inactive ingredients listed ■ if the infection is on your scalp or nails.

DYNAREX GREEN- alcohol liquid Bandaríkin - enska - NLM (National Library of Medicine)

dynarex green- alcohol liquid

dynarex corporation - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - do not use with electrocautery procedures an antiseptic wash. cleaning and antiseptic cleansing of skin.

FLAREX Sterile Ophthalmic Suspension Bottle Ástralía - enska - Department of Health (Therapeutic Goods Administration)

flarex sterile ophthalmic suspension bottle

novartis pharmaceuticals australia pty ltd - fluorometholone acetate, quantity: 1 mg/ml - eye drops, suspension - excipient ingredients: sodium chloride; tyloxapol; benzalkonium chloride; monobasic sodium phosphate; hyetellose; purified water; hydrochloric acid; sodium hydroxide; disodium edetate - indications as at 21 april 1989: flurometholone acetate ophalmic suspension is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye.

AREXVY- respiratory syncytial visus vaccine recombinant, adjuvanted kit Bandaríkin - enska - NLM (National Library of Medicine)

arexvy- respiratory syncytial visus vaccine recombinant, adjuvanted kit

glaxosmithkline biologicals sa - recombinant respiratory syncytial virus pre-fusion f protein (unii: m739eb7427) (recombinant respiratory syncytial virus pre-fusion f protein - unii:m739eb7427) - arexvy is indicated for active immunization for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in individuals 60 years of age and older. do not administer arexvy to anyone with a history of a severe allergic reaction (e.g., anaphylaxis) to any component of arexvy [see description (11)] . risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. arexvy is not approved for use in persons <60 years of age. in a clinical study that enrolled pregnant individuals who received an investigational unadjuvanted rsv vaccine that contained the same rsvpref3 antigen as arexvy, an increase in preterm births was observed compared to pregnant individuals who received placebo (sucrose reconstituted with saline). data in a randomized controlled clinical trial that enroll